Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Ishares Dex Real Return Bond Index Fund
T.XRB
Alternate Symbol(s):
ICDXF
The investment objective of the Fund is to provide income by replicating, to the extent possible, the performance of the FTSE Canada Real Return Bond Index , net of expenses. Under normal market conditions, the Fund will primarily invest in Canadian fixed income securities. The Index is a market capitalization-weighted index consisting of Canadian dollar denominated inflation-linked bonds, which may include any or all of federal, provincial, corporate and municipal bonds, with an investment grade rating and a remaining effective term to maturity of at least one year. To achieve its investment objective the Fund uses an indexing strategy. Under this strategy, the Fund seeks to replicate the performance of the Index, net of expenses, by employing, directly or indirectly, through investment in one or more exchange-traded funds managed by BlackRock Canada or an affiliate and/or through the use of derivatives, a replicating strategy or sampling strategy.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
New Post
TSX:XRB - Post by User
Ishares Dex Real Return Bond Index Fund
Bullboard Posts
(0)
•••
Redundunce
X
View Profile
View Bullboard History
Post by
Redundunce
on Feb 17, 2007 1:51pm
42 Views
Post# 12256559
What inflation?
What inflation?
So I say to myself since no one else is interested: if there is no inflation, how come a small can of dog food now costs more than a large can cost a couple of years ago?
Comment on this Post
Bullboard Posts
Eminent acquires promising Nevada gold project
Three business reasons companies need to recycle e-waste
Critical materials crisis: Diversifying away from China’s monopoly
Invest wiser with BMO's InvestorLine Platform features
A potential breakthrough in spinal cord and optic nerve injury treatment
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
{{ dialogTitle }}
×
Reject Reason
{{ policy.description }}
{{reasonError}}
Additional Comments
{{feedbackError}}
{{buttonTitle}}
Cancel
{{submitMsg}}
Featured News Links
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments